Literature DB >> 12627707

Telomerase: a potential diagnostic and therapeutic tool in canine oncology.

D J Argyle1, L Nasir.   

Abstract

In recent years there has been considerable interest in telomerase as a target for therapeutic intervention in oncology. This largely stems from the vast number of studies that have demonstrated expression and activity of the enzyme telomerase in the majority of human cancer tissues with little or no activity detectable in normal somatic tissues. These studies have led to an interest in the role of telomerase in cancers associated with domesticated species, in particular tumors that affect dogs. This article reviews the biology of telomerase and the biological significance of telomerase activity in canine tumors and discusses the clinical implications of telomerase expression in canine cancers with regard to therapeutics and diagnostics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12627707     DOI: 10.1354/vp.40-1-1

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  13 in total

1.  A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma.

Authors:  Daniela Peruzzi; Alessandra Gavazza; Giuseppe Mesiti; George Lubas; Elisa Scarselli; Antonella Conforti; Claus Bendtsen; Gennaro Ciliberto; Nicola La Monica; Luigi Aurisicchio
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

2.  Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.

Authors:  Alessandra Gavazza; George Lubas; Arthur Fridman; Daniela Peruzzi; Joseph A Impellizeri; Laura Luberto; Emanuele Marra; Giuseppe Roscilli; Gennaro Ciliberto; Luigi Aurisicchio
Journal:  Hum Gene Ther       Date:  2013-08       Impact factor: 5.695

Review 3.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

4.  DNAzyme-based probes for telomerase detection in early-stage cancer diagnosis.

Authors:  Hui Wang; Michael J Donovan; Ling Meng; Zilong Zhao; Youngmi Kim; Mao Ye; Weihong Tan
Journal:  Chemistry       Date:  2013-02-20       Impact factor: 5.236

5.  Immunohistochemical expression of dog TERT in canine testicular tumours in relation to PCNA, ki67 and p53 expression.

Authors:  N Papaioannou; D Psalla; M Zavlaris; P Loukopoulos; N Tziris; I Vlemmas
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

6.  Canis familiaris telomerase reverse transcriptase undergoes alternative splicing.

Authors:  Katerina Angelopoulou; Michael Zavlaris; Nikolaos Papaioannou; Ioannis Vlemmas
Journal:  Mamm Genome       Date:  2008-10-04       Impact factor: 2.957

7.  Establishment of immortalized Schwann cells derived from rat embryo dorsal root ganglia.

Authors:  Huajun Jiang; Wei Qu; Feng Han; Dazhuang Liu; Weiguo Zhang
Journal:  Int J Mol Med       Date:  2012-06-06       Impact factor: 4.101

8.  NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy.

Authors:  Joe N Kornegay; Jennifer M Peterson; Daniel J Bogan; William Kline; Janet R Bogan; Jennifer L Dow; Zheng Fan; Jiahui Wang; Mihye Ahn; Hongtu Zhu; Martin Styner; Denis C Guttridge
Journal:  Skelet Muscle       Date:  2014-10-23       Impact factor: 4.912

9.  Telomere Transcripts Target Telomerase in Human Cancer Cells.

Authors:  Theresa Kreilmeier; Doris Mejri; Marlene Hauck; Miriam Kleiter; Klaus Holzmann
Journal:  Genes (Basel)       Date:  2016-08-16       Impact factor: 4.096

10.  Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.

Authors:  Joe N Kornegay; Daniel J Bogan; Janet R Bogan; Jennifer L Dow; Jiahui Wang; Zheng Fan; Naili Liu; Leigh C Warsing; Robert W Grange; Mihye Ahn; Cynthia J Balog-Alvarez; Steven W Cotten; Monte S Willis; Candice Brinkmeyer-Langford; Hongtu Zhu; Joe Palandra; Carl A Morris; Martin A Styner; Kathryn R Wagner
Journal:  Skelet Muscle       Date:  2016-04-04       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.